FDA Inspection 1228299 — ReConserve of Arizona
The FDA completed an inspection of ReConserve of Arizona on February 1, 2024 in Phoenix, AZ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 1, 2024
- Fiscal Year
- 2024
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Phoenix, AZ (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 21316 | 21 CFR 507.47(b) | Validation Requirements for Preventive Controls |
| 21317 | 21 CFR 507.49(a)(1) | Calibration |